ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,863.70
0.63%
S&P ASX All Technology
3,056.60
0.37%
Brent Oil
83.565
-0.04%
US Dollar vs AUD
1.49413
0.11%
Bitcoin
66,902.18
1.12%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aptevo Therapeutics Inc (APVO)

  7. Aptevo Therapeutics Inc (APVO) News

APVO

Aptevo Therapeutics (APVO)

Aptevo Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APVO
DateTimeSourceHeadlineSymbolCompany
08/05/202422:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
08/05/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
08/03/202400:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
06/03/202409:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
06/03/202408:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
06/03/202408:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
06/03/202400:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APVOAptevo Therapeutics Inc
06/03/202400:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
07/02/202408:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
31/01/202410:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
31/01/202400:00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
17/01/202408:15Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
23/12/202308:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
13/12/202308:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
01/12/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APVOAptevo Therapeutics Inc
23/11/202308:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
10/11/202309:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
04/11/202307:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
16/09/202306:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
11/08/202306:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
11/08/202306:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
10/08/202322:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
10/08/202322:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
10/08/202322:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
10/08/202322:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
10/08/202322:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
04/08/202307:21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APVOAptevo Therapeutics Inc
02/08/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APVOAptevo Therapeutics Inc
02/08/202306:01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APVOAptevo Therapeutics Inc
18/07/202322:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APVO

Your Recent History

NYSE
MHLA
Maiden
AMEX
SIFI
Harbor Scientific Alpha ...
EU
ALSPT
Spartoo
LATK
WBTCBTC
Wrapped BTC
COIN
PCNTUST
Playcent
NASDAQ
ANSCW
Agriculture and Natural ...
BIT
GRAL
Grifal
USOTC
GILXF
Gitennes Exploration (PK)
CREX
BSVBTC
Bitcoin Cash SV
NASDAQ
FZBXOX
Diversified High Income ...
TG
WOSB
Wolters Kluwers NV
LSE
IEGL
Ishr E Gv 15-30
COIN
EVERKRW
Everscale
COIN
AZKUST
Alien ZK
BOV
OIBR4M
OI PN
USOTC
JIAXF
Jiangxi Copper (PK)
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved